PMS40 Cost-Effectiveness of Denosumab for the Treatment of Male Osteoporosis (MOP) in the Elderly in Sweden von Parthan, A, Deflin, M.M, Agodoa, I, Tao, C.Y, Silverman, S.L, Orwoll, E

Volltext

Effect of teriparatide compared with risedronate on back pain and incident vertebral fractures in postmenopausal women with osteoporotic vertebral fractures von Hadji, P, Zanchetta, J.R, Russo, L.A, Recknor, C.P, Saag, K.G, McKiernan, F.E, Silverman, S.L, Alam, J, Burge, R.T, Krege, J.H, Lakshmanan, M.L, Masica, D.N, Mitlak, B.H, Stock, J.L

Volltext

Sustained efficacy of bazedoxifene in preventing fractures in postmenopausal women with osteoporosis: Results of a 5-year, randomized, placebo-controlled study von Silverman, S.L, Chines, A.A, Zanchetta, J.R, Genant, H.K, Kendler, D.L, Rio de la Loza, F, Kung, A.W, Constantine, G.D, Adachi, J.D

Volltext

PMS30 - Is Denosumab Cost-Effective Compared To Oral Bisphosphonates For The Treatment Of Male Osteoporosis (Mop) In Sweden? von Parthan, A., Kruse, M.M., Agodoa, I., Tao, C.Y., Silverman, S.L., Orwoll, E.

Volltext

The clinical consequences of vertebral compression fracture von Silverman, S.L.

Volltext

Increases in Bone Mineral Density with Once-Monthly Ibandronate: A Post Hoc Responder Rate Analysis of the MOBILE Study von Hochberg, M.C., Silverman, S.L., Barr, C.E., Weinerman, S.A.

Volltext

Real-world evidence: new opportunities for osteoporosis research. Recommendations from a working group from the European Society for Clinical and Economic Aspects of Osteoporosis,... von Moon, R.J, Reginster, J.-Y, Al-Daghri, N.M, Thiyagarajan, J.A, Beaudart, C, Bruyère, O, Burlet, N, Chandran, M, da Silva, M.C, Conaghan, P.G, Dere, W.H, Diez-Perez, A, Hadji, P, Halbout, P, Hiligsmann, M, Kanis, J.A, McCloskey, E.V, Ormarsdottir, S, Prieto-Alhambra, D, Radermecker, R.P, Rizzoli, R, Al-Saleh, Y, Silverman, S.L, Simon, L.S, Thomasius, F, van Staa, T, Laslop, A, Cooper, C, Harvey, N.C

Volltext bestellen

Suppression of Bone-Turnover Markers at 3 months is Maintained at 2 Years with Once-Monthly Ibandronate: MOBILE 2-Year Data von Lewiecki, E.M., Miller, P.D., Civitelli, R., Sydney, M., Stella, H., Silverman, S.L.

Volltext

Suppression of Bone-Turnover Markers at 3 months is Maintained at 2 Years with Once-Monthly Ibandronate: MOBILE 2-Year Data von Lewiecki, E.M., Miller, P.D., Civitelli, R., Sydney, M., Stella, H., Silverman, S.L.

Volltext

Modelling of Serum CTX Levels with Daily and Monthly Oral Ibandronate von Silverman, S.L., Derman, R.J., Civitelli, R., Sydney, M., Stella, H., Ettinger, M.P., Gieschke, R., Friend, K.E., Epstein, S.

Volltext

Modelling of Serum CTX Levels with Daily and Monthly Oral Ibandronate von Silverman, S.L., Derman, R.J., Civitelli, R., Sydney, M., Stella, H., Ettinger, M.P., Gieschke, R., Friend, K.E., Epstein, S.

Volltext

Effect of bone density information on decisions about hormone replacement therapy: A randomized trial von Silverman, S.L., Greenwald, M., Klein, R.A., Drinkwater, B.L.

Volltext

Case report von Silverman, S.L.

Volltext

Non-destructive detection of phosphorus oxide layers on semiconductor wafers von Corl, E.A., Silverman, S.L., Kim, Y.S.

Volltext

Worldwide comparison of ovarian cancer survival: Histological group and stage at diagnosis (CONCORD-2) von Matz, Melissa, Coleman, Michel P, Carreira, Helena, Salmerón, Diego, Chirlaque, Maria Dolores, Allemani, Claudia

Volltext

The histology of ovarian cancer: worldwide distribution and implications for international survival comparisons (CONCORD-2) von Matz, Melissa, Coleman, Michel P, Sant, Milena, Chirlaque, Maria Dolores, Visser, Otto, Gore, Martin, Allemani, Claudia

Volltext

Elevated prevalence of 35-44 FMR1 trinucleotide repeats in women with diminished ovarian reserve von Pastore, L.M, Young, S.L, Baker, V.L, Karns, L.B, Williams, C.D, Silverman, L.M

Volltext

Diet-related modification of cuticular hydrocarbon profiles of the Argentine ant, Linepithema humile, diminishes intercolony aggression von Buczkowski, G, Kumar, R, Suib, S.L, Silverman, J

Volltext

Functional similarity and physical association between GCN5 and ADA2: putative transcriptional adaptors von Marcus, G.A, Silverman, N, Berger, S.L, Horiuchi, J, Guarente, L

Volltext

Escalation of daunorubicin and addition of etoposide in the ADE regimen in acute myeloid leukemia patients aged 60 years and older: Cancer and Leukemia Group B Study 9720 von Baer, M R, George, S L, Sanford, B L, Mrózek, K, Kolitz, J E, Moore, J O, Stone, R M, Powell, B L, Caligiuri, M A, Bloomfield, C D, Larson, R A

Volltext